Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Hepatology
•
Transplant Hepatology
With an increase in the prevalence of MASLD in the United States population, what recipient and donor characteristics do you find favorable for acceptance of a highly steatotic graft?
Related Questions
How do you counsel patients on the use of marginal organs and/or high risk donors who are on the liver transplant wait list?
How do you determine when you would treat an identified spleno-renal shunt and how?
For how long would you treat a patient with latent TB before allowing them to proceed with a liver transplant?
What patient features would favor the creation of a Hutson loop intra-operatively?
How do you determine which patients are good candidates to have their organ receive machine perfusion therapy before implantation?
How do you approach risk of development of PTLD in liver transplant recipients with positive EBV antibodies and/or viral loads?
What would be the right patient profile and experience for someone who may have (operational) tolerance and how do you approach immunosuppresison management (or withdrawal) in this patient?
How do you approach the evaluation of a living donor liver transplant candidate? What kind of patient would be an ideal recipient of such an organ?
How much do you factor in a patient's frailty in selection for transplant if the underlying driver for their debility is their underlying liver disease itself?
How has the move away from a strict 6 month period of sobriety impacted your patient selection criteria for transplant of patients with alcohol associated liver disease?
